K. Heller

发表

Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment.

M. Scheinman, M. Lesh, J. Kalman, 1997, The American journal of cardiology.

Attitudes of attending physicians to the incidental diagnosis of hypercholesterolemia in hospitalized patients.

S. Viskin, E. Lev, S. Laniado, 1995, The American journal of cardiology.

Drug-induced Brugada syndrome: Clinical characteristics and risk factors.

P. Postema, S. Viskin, D. Zeltser, 2016, Heart rhythm.

Torsade de Pointes Due to Noncardiac Drugs: Most Patients Have Easily Identifiable Risk Factors

S. Viskin, D. Zeltser, A. Halkin, 2003, Medicine.

Life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?

S. Viskin, A. Steinvil, A. Halkin, 2014, Journal of the American College of Cardiology.

The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies.

J. Olgin, M. Scheinman, H. Barron, 1997, Current problems in cardiology.

J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.

S. Viskin, M. Scheinman, M. Glikson, 2008, Journal of the American College of Cardiology.

Fever-induced Brugada pattern: how common is it and what does it mean?

S. Viskin, C. Antzelevitch, S. Ben-Shachar, 2013, Heart rhythm.

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.

S. Viskin, E. Lev, S. Laniado, 1995, Journal of the American College of Cardiology.

Mode of onset of torsade de pointes in congenital long QT syndrome.

S. Viskin, M. Scheinman, M. Lesh, 1996, Journal of the American College of Cardiology.

Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?

S. Viskin, D. Zeltser, H. Barron, 2000, Heart.

The importance of creatine kinase determination in identifying acute myocardial infarction among patients complaining of chest pain in an emergency room.

S. Viskin, S. Shibolet, K. Heller, 1987, Cardiology.

Postextrasystolic U wave augmentation, a new marker of increased arrhythmic risk in patients without the long QT syndrome.

J. Olgin, M. Lesh, H. Barron, 1996, Journal of the American College of Cardiology.

Clonidine for Patients with Rapid Atrial Fibrillation

E. Kaluski, S. Laniado, A. Roth, 1992, Annals of Internal Medicine.